Allspring Global Investments’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$460K Buy
21,041
+2,168
+11% +$46.8K ﹤0.01% 1412
2025
Q4
$440K Buy
18,873
+1,649
+10% +$33.6K ﹤0.01% 1411
2025
Q3
$232K Sell
17,224
-170
-1% -$1.77K ﹤0.01% 1530
2025
Q2
$145K Sell
17,394
-1,011
-5% -$8.64K ﹤0.01% 1569
2025
Q1
$144K Buy
18,405
+6,453
+54% +$74.8K ﹤0.01% 1679
2024
Q4
$178K Buy
11,952
+28
+0.2% +$457 ﹤0.01% 1685
2024
Q3
$182K Sell
11,924
-884
-7% -$13.9K ﹤0.01% 1688
2024
Q2
$195K Sell
12,808
-132
-1% -$2.13K ﹤0.01% 1711
2024
Q1
$244K Buy
12,940
+1,090
+9% +$18.8K ﹤0.01% 1665
2023
Q4
$226K Buy
11,850
+2,516
+27% +$40.2K ﹤0.01% 1665
2023
Q3
$168K Buy
9,334
+230
+3% +$4.62K ﹤0.01% 1810
2023
Q2
$185K Sell
9,104
-6,968
-43% -$133K ﹤0.01% 1833
2023
Q1
$293K Buy
16,072
+3,703
+30% +$70.8K ﹤0.01% 1726
2022
Q4
$256K Sell
12,369
-828
-6% -$22.8K ﹤0.01% 1769
2022
Q3
$345K Buy
13,197
+3,315
+34% +$87.7K ﹤0.01% 1665
2022
Q2
$250K Sell
9,882
-9,668
-49% -$237K ﹤0.01% 1753
2022
Q1
$616K Sell
19,550
-700
-3% -$23.5K ﹤0.01% 2133
2021
Q4
$819K Buy
+20,250
New +$786K ﹤0.01% 2055

Other funds holding RCUS

Allspring Global Investments's RCUS Position: Q1 2026 in Review

Allspring Global Investments increased its Arcus Biosciences (RCUS) stake by 11% in Q1 2026, buying an estimated $46.8K and bringing the position to 21,041 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #1412.

Allspring Global Investments first reported a position in RCUS in Q4 2021 and has held it in 18 quarters since. The position peaked at $819K in Q4 2021. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Allspring Global Investments held 21,041 shares of Arcus Biosciences worth $460K as of Q1 2026.
  • Allspring Global Investments bought 2,168 Arcus Biosciences shares in Q1 2026, an estimated $46.8K.
  • Arcus Biosciences made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1412 holding.
  • Allspring Global Investments first reported a position in Arcus Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Arcus Biosciences position peaked at $819K in Q4 2021.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.